https://www.selleckchem.com/
Digoxin is commonly prescribed for heart failure and atrial fibrillation, but there is limited data on its safety in patients with chronic kidney disease (CKD). We conducted a population-based cohort study using the pre-end stage renal disease (ESRD) care program registry and the National Health Insurance Research Database in Taiwan. Of advanced CKD patient cohort (N = 31,933), we identified the digoxin user group (N = 40 matched with age and sex non-user group (N = 2,22. Multivariable Cox proportional hazards and sub-distribution hazards models were us
Like
Comment
Share
